SARS-CoV-2 RT-PCR Detection Using Segmented Primer-Probe Sets
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is an urgent need for methods and reagents that can detect the presence and absence of SARS-CoV-2 with high specificity and sensitivity, as existing technologies face challenges in accurately identifying the virus amidst other respiratory infections.
Innovation Solution
The development of novel nucleic acid primers and probes that target specific sequences of the SARS-CoV-2 RNA, enabling reverse transcription, amplification, and detection through RT-PCR, with sequences such as 5′-ACAACACAACAAAGGGAG-3′ and 5′-TACCGGCAGCACAAGACATCT-3′, allowing for 100% positive detection as low as 100 copies of target RNA per reaction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional RT-PCR methods are used for SARS-CoV-2 detection, then the detection can be performed with standard reagents, but the sensitivity and specificity are insufficient to accurately distinguish SARS-CoV-2 from other coronaviruses and respiratory viruses
Solution Approach 1:
The detection system is segmented into multiple independent components: two separate primer-probe sets targeting different regions of the SARS-CoV-2 genome (ORF1ab and N genes). Each set independently detects specific viral sequences, allowing the system to achieve high specificity by requiring concordant positive results from both targets while maintaining manageable complexity through modular design
Solution Approach 2:
The primers and probes are designed with locally optimized sequences that specifically bind to unique regions of the SARS-CoV-2 genome. The forward and reverse primers for each target region are tailored to match specific local sequences, ensuring high specificity for SARS-CoV-2 detection while distinguishing it from other coronaviruses and respiratory viruses
2Measurement precision
If existing detection methods are used, then the assay can be performed with standard sensitivity, but the detection limit is insufficient to detect low viral loads as low as 100 copies per reaction
Solution Approach 1:
The method performs preliminary reverse transcription of the viral RNA into cDNA before the amplification step. This preliminary conversion of RNA to stable cDNA form enhances the sensitivity of subsequent PCR detection, allowing detection of very low viral loads (100 copies/reaction) by ensuring efficient conversion and preservation of the target material before amplification begins
Solution Approach 2:
The detection method uses PCR amplification to create multiple copies of the viral target sequences. The forward and reverse primers facilitate exponential amplification of the cDNA templates, generating sufficient copy numbers from low initial viral loads to enable sensitive detection while maintaining efficient use of reagents through targeted amplification
3Adaptability or versatility
If the detection method targets multiple coronavirus types, then broader detection coverage is achieved, but the ability to specifically identify SARS-CoV-2 among other viruses is reduced
Solution Approach 1:
The detection system is segmented into multiple independent components: two separate primer-probe sets targeting different regions of the SARS-CoV-2 genome (ORF1ab and N genes). Each set independently detects specific viral sequences, allowing the system to achieve high specificity by requiring concordant positive results from both targets while maintaining manageable complexity through modular design
Solution Approach 2:
The primers and probes are designed with locally optimized sequences that specifically bind to unique regions of the SARS-CoV-2 genome. The forward and reverse primers for each target region are tailored to match specific local sequences, ensuring high specificity for SARS-CoV-2 detection while distinguishing it from other coronaviruses and respiratory viruses
Data Source
AI summary
Methods, primers, sets of primers, probes, compositions, and kits for detecting presence or absence of SARS-CoV-2 in a sample are provided.